Open AccessFibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis
Author(s) -
Beth Wallace,
Meriah N. Moore,
Andrew C. Heisler,
Lutfiyya N. Muhammad,
Jing Song,
Daniel J. Clauw,
Clifton O. Bingham,
Marcy B Bolster,
Wendy Marder,
Tuhieogi,
Alyssa Wohlfahrt,
Dorothy D. Dunlop,
Yvonne Lee
Publication year - 2021
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/keab583
Subject(s) - prednisone , medicine , glucocorticoid , rheumatoid arthritis , logistic regression , odds ratio , persistence (discontinuity) , cohort , erythrocyte sedimentation rate , physical therapy , geotechnical engineering , engineering
Over one-third of patients with RA exhibit evidence of fibromyalgianess, which is associated with higher rates of disability and inadequate responsiveness to RA treatment. Patients with RA often remain on glucocorticoids long-term, despite the known risk of dose-dependent morbidity. We undertook this study to examine the relationship between fibromyalgianess and glucocorticoid persistence among RA patients.